Generated $3.6 Million in Revenue from Operations in Pennsylvania, Nevada, and New York;

Cresco Labs Inc. ("Cresco Labs"- CSE: CL, OTCQX: CRLBF) and CannaRoyalty Corp. d/b/a Origin House ("Origin House"- CSE: OH, OTCQX: ORHOF) today announced that, in connection with the previously announced plan of arrangement pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Origin House in an all-stock transaction (the "Arrangement"), the parties have agreed to an amendment (the "Amendment") to the arrangement agreement dated April 1, 2019 (as amended, the "Arrangement Agreement") to provide for certain changes to the covenants and agreements contained therein. In connection with the Amendment, Origin House will also complete a non-brokered financing (the "Financing") of up to 9,705,882 common shares of Origin House ("Common Shares") at a price of C$4.08 per Common Share for aggregate gross proceeds of C$39,600,000 (approximately US$30 million) to strengthen the balance sheet of the combined company. The Financing is fully subscribed, and the proceeds of the Financing will be held in escrow pending closing of the Arrangement. In addition, certain persons, including services providers, have agreed to be paid amounts owing to them by Origin House in Common Shares.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco" or the "Company"), one of the largest vertically integrated multistate cannabis operators in the United States, will report its financial results for the third quarter ended September 30, 2019, on Tuesday, November 26, 2019 after the market closes.